JFG
REGN icon

Jefferies Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Jefferies Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,700
Closed -$7.62M – 1931
2024
Q4 		$7.62M Buy
+10,700
New +$8.98M 0.05% 269
2023
Q2 		– Sell
-7,000
Closed -$5.75M – 1945
2023
Q1 		$5.75M Buy
+7,000
New +$5.28M 0.05% 324

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jefferies Financial Group's REGN Position: Q2 2026 in Review

Jefferies Financial Group increased its Regeneron Pharmaceuticals (REGN) stake by 46% in Q2 2026, buying an estimated $4.26M and bringing the position to 19,740 shares worth $12.3M. The position accounts for 0.08% of the portfolio, ranked #213.

Jefferies Financial Group first reported a position in REGN in Q1 2018 and has held it in 17 quarters since. The position peaked at $28.9M in Q3 2024. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Jefferies Financial Group held 19,740 shares of Regeneron Pharmaceuticals worth $12.3M as of Q2 2026.
  • Jefferies Financial Group bought 6,259 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.26M.
  • Regeneron Pharmaceuticals made up 0.08% of Jefferies Financial Group's portfolio in Q2 2026, its #213 holding.
  • Jefferies Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2018 and has held it in 17 quarters since.
  • Jefferies Financial Group's Regeneron Pharmaceuticals position peaked at $28.9M in Q3 2024.
  • 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.